Differential carnitine/acylcarnitine translocase expression defines distinct metabolic signatures in skeletal muscle cells

Journal of Cellular Physiology

Volumn 203, Issue 2, 2005, Pages 439-446

  Peluso, Gianfranco ^a   Petillo, Orsolina ^a,b   Margarucci, Sabrina ^b   Grippo, Pasquale ^c   Melone, Mariarosa Anna Beatrice ^c   Tuccillo, Franca ^a   Calvani, Menotti ^d  

^a NATIONAL CANCER INSTITUTE   (Italy)

^b INSTITUTE OF PROTEIN BIOCHEMISTRY   (Italy)

^c SECOND UNIVERSITY OF NAPLES   (Italy)

^d Sigma Tau SpA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYL COENZYME A CARBOXYLASE; ACYLCARNITINE; ACYLCARNITINE CARNITINE TRANSLOCASE; ADENOVIRUS VECTOR; CARNITINE; CARNITINE PALMITOYLTRANSFERASE; CARRIER PROTEIN; COMPLEMENTARY RNA; MALONYL COENZYME A; PALMITIC ACID; UNCLASSIFIED DRUG;

ARTICLE; CATABOLISM; CONTROLLED STUDY; CYTOSOL; ENERGY; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; LIPID METABOLISM; LIPID OXIDATION; MITOCHONDRIAL MEMBRANE; MUSCLE CELL; MUSCLE MITOCHONDRION; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; SKELETAL MUSCLE;

ACETYL-COA CARBOXYLASE; ACETYLCARNITINE; ACYL COENZYME A; ANTISENSE ELEMENTS (GENETICS); CARNITINE; CARNITINE ACYLTRANSFERASES; CARNITINE O-PALMITOYLTRANSFERASE; CELL LINE; DOWN-REGULATION; ENERGY METABOLISM; GENE EXPRESSION REGULATION, ENZYMOLOGIC; HUMANS; INSULIN; LIPID METABOLISM; MALONYL COENZYME A; MITOCHONDRIA; MUSCLE FIBERS; MUSCLE, SKELETAL; PALMITATES; RNA, ANTISENSE;

ADENOVIRIDAE;

EID: 16344376548     PISSN: 00219541     EISSN: None     Source Type: Journal    
DOI: 10.1002/jcp.20239     Document Type: Article

References (31)

1. Abu-Elheiga L, Almarza-Ortega DB, Baldini A, Wakil SJ. 1997. Human acetyl-CoA carboxylase 2 molecular cloning, characterization, chromosomal mapping, and evidence for two isoforms. J Biol Chem 272:10669-10677.
2. Antinozzi PA, Segall L, Prentki M, McGarry JD, Newgard CB. 1998. Molecular or pharmacologic perturbation of the link between glucose and lipid metabolism is without effect on glucose-stimulated insulin secretion. A re-evaluation of the long-chain acyl-CoA hypothesis. J Biol Chem 273:16146-16154.
3. Baillet L, Mullur RS, Esser V, McGarry JD. 2000. Elucidation of the mechanism by which (+)-acylcarnitines inhibit, mitochondrial fatty acid transport. J Biol Chem 275:36766-36768.
4. Benders AAGM, Van Kuppevelt THMSM, Oosterhof A, Veerkamp JH. 1991. The biochemical and structural maturation of human skeletal muscle cells in culture: The effect of the serum substitute. Ultroser G Exp Cell Res 195:284-294.
5. Bergseth S, Lund H, Poisson JP, Bremer J, Davis-Van Thienen W, Davis EJ. 1986. Carnitine palmitoyltransferase: Activation and inactivation in liver mitochondria from fed, fasted, hypo- and hyperthyroid rats. Biochm Biophys Acta 876:551-558.
6. Broderick TL, Quinney HA, Lopaschuk GD. 1992. Carnitine stimulation of glucose oxidation in the fatty acid perfused isolated working rat heart. J Biol Chem 267:3758-3763.
7. Giordano A, Calvani M, Petillo O, Carteni' M, Melone MAB, Peluso G. 2003. Skeletal muscle metabolism in physiology and in cancer disease. J Cell Biochem 90:170-186.
8. Ha J, Lee J-K, Kim K-S, Wittes LA, Kim K-H. 1996. Cloning of human acetyl-CoA carboxylase-β and its unique features. Proc Natl Acad Sci USA 93:1146-11470.
9. Hopkins TA, Dick JRB, Lopaschuk GD. 2003. AMP-activated protein kinase regulation of fatty acid oxidation in the ischemic heart. Biochem Soc Transac 31:207-212.
10. Huizing M, Ruitenbeek W, van den Heuvel LP, Dolce V, Iacobazzi V, Smeitink J, Palmieri F, Trijbels JMF. 1998. Human mitochondrial transmembrane metabolite carriers: Tissue distribution and its implication for mitochondrial disorders. J Bioenerg Biomembr 30:277-284.
11. Jong-Yeon K, Hickner RC, Cortright RL, Dohm GL, Houmard JA. 2000. Lipid oxidation is reduced in obese human skeletal muscle. Am J Physiol Endocrinol Metab 279:E1039-E1044.
12. Kelley DE, Goodpaster BH. 2001. Skeletal muscle triglyceride. An aspect of regional adiposity and insulin resistance. Diabetes Care 24:933-941.
13. Kelley DE, Goodpaster BH, Wing RR, Simoneau JA. 1999. Skeletal muscle fatty acid metabolism in association with insulin resistance, obesity and weight loss. Am J Physiol 277:E1130-E1141.
14. Kerner J, Hoppel C. 2000. Fatty acid import into mitochondria. Biochim Biophys Acta 1486:1-17.
15. Listenberger LL, Han X, Lewis SE, Cases S, Farese RV, Jr., Dry DS, Schaffer JE. 2003. Triglyceride accumulation protects against fatty acid-induced lipotoxicity. Proc Natl Acad Sci USA 100:3077-3082.
16. Liu G, Chen J, Che P, Ma Y. 2003. Separation and quantitation of short-chain coenzyme A's in biological samples by capillary electrophoresis. Anal Chem 75:78-82.
17. Lysiak W, Toth PP, Suelter CH, Bieber LL. 1986. Quantitation of the efflux of acylcarnitines from rat heart, brain, and liver mitochondria. J Biol Chem 261:13698-13703.
18. Manco M, Mingrone G, Greco AV, Capristo E, Gnauli D, De Gaetano A, Gasbarrini G. 2000. Insulin resistance directly correlates with increased saturated fatty acids in skeletal muscle triglycerides. Metabolism 49:220-224.
19. Pande S, Murthy MSR. 1994. Carnitine-acylcarnitine translocase deficiency: Implications in human pathology. Biochim Biophys Acta 1226:269-276.
20. Patel MS, Roche TE. 1990. Molecular biology and biochemistry of pyruvate dehydrogenase complexes. FASEB J 4:3224-3233.
21. Peluso G, Petillo O, Margarucci S, Mingrone G, Greco AV, Indiveri C, Palmieri F, Melone MAB, Reda E, Calvani M. 2002. Decreased mitochondrial carnitine translocase in skeletal muscles impairs utilization of fatty acids in insulin-resistant patients. Front Biosci 7:109-116.
22. Ramsay RR, Gandour RD, van der Laij FR. 2001. Molecular enzymology of carnitine transfer and transport. Biochim Biophys Acta 1546:21-43.
23. Rasmussen BB, Holmback UC, Volpi E, Morio-Liondore B, Paddon-Jones D, Wolfe RR. 2002. Malonyl coenzyme A and the regulation of functional carnitine palmitoyltransferase-1 activity and fat oxidation in human skeletal muscle. J Clin Invest 110:1687-1693.
24. Reszko AE, Kasumov T, Comte B, Pierce BA, David F, Bederman IR, Deutsch J, Des Rosiers C, Brunengraber H. 2001. Assay of the concentration and 13C-isotopic enrichment of malonyl-coenzyme A by gas chromatography-mass spectrometry. Anal Biochem 298:69-75.
25. Ruderman NB, Saha AK, Vavvas D, Witters LA. 1999. Malonyl-CoA, fuel sensing, and insulin resistance. Am J Physiol Endocrinol Metab 276:E1-E18.
26. Saddik M, Gamble J, Witters LA, Lopaschuk GD. 1993. Acetyl-CoA carboxylase regulation of fatty acid oxidation in the heart. J Biol Chem 268:25836-25845.
27. Schönherr E, O'Connell BC, Schittny J, Robenek H, Fastermann D, Fisher LW, Plenz G, Vischer P, Young MF, Kresse H. 1999. Paracrine or virus-mediated induction of decorin expression by endothelial cells contributes to tube formation and prevention of apoptosis in collagen lattices. Eur J Cell Biol 78:44-55.
28. Shepherd D, Garland PB. 1969. Citrate synthase from rat liver. Methods Enzymol 13:11-16.
29. Sim KG, Carpenter K, Hammond J, Christodoulou J, Wilcken B. 2002. Acylcarnitine profiles in fibroblasts from patients with respiratory chain defects can resemble those from patients with mitochondrial fatty acid β-oxidation disorders. Metabolism 51:366-371.
30. Tamvakopoulos CS, Willi S, Anderson VE, Hale DE. 1995. Long-chain acyl-CoA profiles in cultured fibroblasts from patients with defects in fatty acid oxidation. Biochem Mol Med 55:15-21.
31. Vescovo G, Ravara B, Gobbo V, Sandri M, Angelini A, Della Barbera M, Dona M, Peluso G, Calvani M, Mosconi L, Dalla Libera L. 2002. L-carnitine: A potential treatment for blocking apoptosis and preventing skeletal muscle myopathy in heart failure. Am J Physiol Cell Physiol 283:C802-C810.